JPIF

The Joint Polish Investment Fund (JPIF) is a venture capital firm based in Warsaw, Poland, established in 2015. The fund primarily focuses on investments in life sciences, targeting early-stage and mid-stage companies, particularly those with clear and near-term value inflection points. JPIF typically holds investments for a period of 3-5 years, aiming to achieve significant growth and value creation during that time. The fund has a specific interest in sectors such as therapeutic devices, monitoring equipment, and personalized medicine, with investments made in companies like Fixnip and DreamJay. JPIF's strategy involves not only providing financial support but also leveraging its team's extensive experience in the life sciences to guide these companies towards successful commercialization. JPIF is led by Kreske Nickelsen, the CEO, along with a team of general partners who bring diverse expertise to the fund's operations. The firm operates under the broader European venture capital landscape, contributing to the growth of innovative life science companies in Central and Eastern Europe.